Medical cannabis is receiving increasing consideration as an effective treatment option for a variety of serious conditions
The scientific research on the therapeutic efficacy of medical cannabisConsult the research library
What conditions are being considered for cannabinoid therapy?
There are no restrictions imposed by Australia's regulatory authority, the Therapeutic Goods Administration (TGA), on the conditions or symptoms for which a medical practitioner may apply to access medicinal cannabis products for their patient.
On June 2021, over 215 conditions had been accepted for medicinal cannabis use, with over 65% of SAS B approvals having been granted for the treatment of chronic pain of unspecified origin.
Other common indications include other pain conditions (cancer pain and symptom management and neuropathic pain and fibromyalgia), seizure management/epilepsy and psychological conditions (anxiety, anorexia, insomnia, post-traumatic stress disorder) and multiple sclerosis and movement disorders (reference: Submission to the
Senate Community Affairs References Committee).
Below are some conditions that have extensive research associated with the use of medicinal cannabis.